QS/1 Offers Pharmacy Therap Interface
October 27th 2016QS/1 is excited to release one of the first pharmacy-to-agency interfaces for Therap, the leading provider in electronic records and documentation in long-term care environments for people with intellectual and developmental disabilities.
Read More
Crisaborole for Atopic Dermatitis
October 27th 2016Atopic Dermatitis (AD) is a chronic, pruritic, relapsing inflammatory skin disease. AD onset is most common between 3 months and 6 months of age, with approximately 60% of patients developing the eruption in the first year of life and 90% by 5 years of age. The majority of affected individuals (70% to 90%) have resolution of disease by adulthood
Read More
Combined Insulin Degludec and Aspart in Insulin-Naïve Patients
October 27th 2016Patients with type 2 diabetes eventually need insulin therapy as their disease progresses. The American Diabetes Association recommends basal-only therapy initially, with the addition of bolus meal-time insulin as needed. However, recent research supports starting patients on combined basal-bolus regimens to control blood sugar regardless of added hypoglycemia risk.
Read More